← Back to Patent Explorer
US4308255A Expired / Lapsed US ⏱️ 0.0 years remaining

Balanced oncotic pressure fluid

Assignee: SCOTT HERBERT R AS CO-TRUSTEE OFR ANGEL C ACEVEDO
•
Filing: 1980-03-24
•
Granted: 1981-12-29
•
Expires: 2000-03-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A balanced oncotic pressure fluid suitable as a dialysate in the treatment of patients suffering from loss of kidney function. The solution comprises on the basis of 1 liter of solution about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, and about 2-10% by weight dextran, the ratio of sodium to chloride being about 1.4:1. An example of the above solution contains about 224 mEq sodium, about 164 mEq chloride, about 72 mEq acetate, about 6% by weight dextran, about 2% dextrose, about 7 mg zinc gluconate, about 2 mEq potassium, about 3 mEq calcium, and about 2 mEq magnesium.

Inventors

  • 👤 Ghen M. G. Raj
  • 👤 Charles L. Fox, Jr.

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:00
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/14

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 66 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by hemodialysis, an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, and about 2-10% by weight dextran, the ratio of sodium to chloride being about 1.4:1.
Claim 2
Independent Claim 66 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by hemodialysis, an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, and about 2-10% by weight dextran, the ratio of sodium to chloride being about 1.4:1.
Claim 3
Independent Claim 66 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by peritoneal dialysis, an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, and about 2-10% by weight dextran, the ratio of sodium to chloride being 1.4:1.
Claim 4
Independent Claim 66 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by peritoneal dialysis, an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, and about 2-10% by weight dextran, the ratio of sodium to chloride being 1.4:1.
Claim 5
Independent Claim 94 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by hemodialysis an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, about 2-10% by weight dextran, up to about 5% by weight dextrose, up to about 15 mg of zinc gluconate, about 1.5-2.5 mEq magnesium, about 1-5.5 mEq potassium, and up to about 5.5 mEq calcium, the sodium to chloride ratio being about 1.4:1.
Claim 6
Independent Claim 94 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by hemodialysis an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, about 2-10% by weight dextran, up to about 5% by weight dextrose, up to about 15 mg of zinc gluconate, about 1.5-2.5 mEq magnesium, about 1-5.5 mEq potassium, and up to about 5.5 mEq calcium, the sodium to chloride ratio being about 1.4:1.
Claim 7
Independent Claim 95 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by peritoneal dialysis an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, about 2-10% by weight dextran, up to about 5% by weight dextrose, up to about 15 mg of zinc gluconate, about 1.5-2.5 mEq magnesium, about 1-5.5 mEq potassium, and up to about 5.5 mEq calcium, the sodium to chloride ratio being about 1.4:1.
Claim 8
Independent Claim 95 words
A method of treating a human suffering from loss of kidney function which comprises administering to said human by peritoneal dialysis an effective amount of a solution comprising, on the basis of 1 liter of solution, about 200-300 mEq sodium, about 145-215 mEq chloride, about 55-85 mEq bicarbonate or acetate or lactate, about 2-10% by weight dextran, up to about 5% by weight dextrose, up to about 15 mg of zinc gluconate, about 1.5-2.5 mEq magnesium, about 1-5.5 mEq potassium, and up to about 5.5 mEq calcium, the sodium to chloride ratio being about 1.4:1.
Claim 9
Dependent Claim 50 words
A method according to claim 3 wherein the solution contains about 224 mEq sodium, about 164 mEq chloride, about 72 mEq acetate, about 6% by weight dextran, about 2% by weight dextrose, about 7 mg zinc gluconate, about 2 mEq magnesium, about 2 mEq potassium, and about 3 mEq calcium.
Claim 10
Dependent Claim 50 words
A method according to claim 4 wherein the solution contains about 224 mEq sodium, about 164 mEq chloride, about 72 mEq acetate, about 6% by weight dextran, about 2% by weight dextrose, about 7 mg zinc gluconate, about 2 mEq magnesium, about 2 mEq potassium, and about 3 mEq calcium.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-12-28 1985-06-29 1985-12-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-12-28 1989-06-29 1989-12-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-12-28 1993-06-29 1993-12-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag